ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1405

Five-Year Changes in Myocardial Structure and Function in Patients with Rheumatoid Arthritis

John M. Davis III1, Grace Lin2, Jae Oh3, Cynthia S. Crowson4, Terry M. Therneau5, Eric L. Matteson1 and Sherine E. Gabriel6, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiology, Mayo Clinic, Rochester, MN, 3Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Rochester, MN, 5Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 6Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Imaging, myocardial involvement and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Patients with rheumatoid arthritis (RA) suffer an increased risk of heart failure not explained by traditional cardiovascular risk factors.  Previously, we have shown that these patients have a high prevalence of abnormal left ventricular (LV) diastolic dysfunction and altered ventricular geometry.  The objective of this study was to evaluate longitudinal changes in LV structure and function in patients with RA.

Methods: A prospective longitudinal study of patients with RA from our community population-based inception cohort was performed.  RA was defined according to the 1987 classification criteria.  Patients were seen at study baseline (2007 – 2009) and approximately 5 years later (2012 – 2014).  For each participant, a registered diagnostic cardiac sonographer performed pulse wave and tissue Doppler echocardiography according to a standardized research protocol.  LV diastolic function parameters were analyzed according to guidelines and criteria of the American Society of Echocardiography.  Medical records were reviewed to ascertain demographics, cardiovascular risk factors, and RA disease characteristics.  Changes in the echo parameters between baseline and 5 years were tested using paired t-tests.

Results:   A total of 137 patients to date have been studied at the 5-year time point.  The mean age was 58.4 years, disease duration 9.6 years, and 76% were female.  The E/e’ ratio increased from 8.7 to 10.9 (p<0.001), consistent with increasing filling pressures of the left ventricle (Table).  The left atrial volume index increased from 25.6 to 34.3 (p <0.001).  The LV mass index and relative wall thickness decreased over time.  On average, there was no biologically relevant change in the ejection fraction over time.

 

Measurement

Baseline

Mean (SD)

5 Years

Mean (SD)

Mean Difference

P-value

LV ejection fraction, %

62.0 (5.8)

61.2 (4.6)

-0.8 (6.3)

0.13

E velocity, m/s

0.69 (0.17)

0.7 (0.17)

0.01 (0.17)

0.53

A velocity , m/s

0.43 (0.1)

0.71 (0.21)

0.28 (0.25)

<0.001

Tissue Doppler e’, m/s

0.08 (0.02)

0.07 (0.02)

-0.02 (0.02)

<0.001

E/A ratio

1.7 (0.4)

1.1 (0.4)

-0.6 (0.6)

<0.001

E/e’ ratio

8.7 (2.9)

10.9 (3.9)

2.2 (3.4)

<0.001

Left atrial volume index, mL/m2

25.6 (5.4)

34.3 (8.7)

8.6 (7.9)

<0.001

LV mass index, gm/m2

80.7 (14.9)

77.3 (18.4)

-3.4 (17.5)

0.06

Relative wall thickness

0.40 (0.07)

0.36 (0.07)

-0.04 (0.08)

<0.001

Conclusion:   In this sample of patients with RA, clinically significant worsening in cardiac structure and function occurred during 5 years of follow-up, including progression of diastolic dysfunction.  Additionally, decline in the LV mass index was observed, which contrasts the expected increased LV mass associated with diastolic dysfunction (hypertrophy).  Future work is necessary to compare these findings to age-related changes in the general population in order to better understand the significance of the results with respect to the risk of future heart failure.

 


Disclosure:

J. M. Davis III,
None;

G. Lin,
None;

J. Oh,
None;

C. S. Crowson,
None;

T. M. Therneau,
None;

E. L. Matteson,
None;

S. E. Gabriel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/five-year-changes-in-myocardial-structure-and-function-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology